Clinical trial
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial…
NCT00035477 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00035477 |
|---|---|
| Title | Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation |
| Official title | Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Azimilide Dihydrochloride, Placebo |
| Enrollment | 446 |
| Start date | Sep 1, 2000 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | May 6, 2002 |
| Last update posted | Oct 3, 2011 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: